ACW — Actinogen Medical Balance Sheet
0.000.00%
Last trade - 00:00- AU$181.10m
- AU$167.86m
- AU$0.69m
Annual balance sheet for Actinogen Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 13.5 | 16.4 | 8.46 | 9.45 | 16.5 |
| Net Total Receivables | 1.54 | 3.94 | 4.12 | 9.32 | 5.8 |
| Prepaid Expenses | |||||
| Total Current Assets | 15.1 | 20.4 | 12.7 | 18.9 | 22.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.254 | 0.169 | 0.113 | 0.341 | 0.27 |
| Net Intangible Assets | |||||
| Total Assets | 18.4 | 23.3 | 15.2 | 21.3 | 24.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.755 | 1.48 | 1.8 | 1.36 | 5.96 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.92 | 1.57 | 1.8 | 1.62 | 6.15 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 17.5 | 21.7 | 13.4 | 19.7 | 18.3 |
| Total Liabilities & Shareholders' Equity | 18.4 | 23.3 | 15.2 | 21.3 | 24.5 |
| Total Common Shares Outstanding |